B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 13 820 KRW 2.37% Market Closed
Market Cap: 117.9B KRW
Have any thoughts about
Bio-FD&C Co Ltd?
Write Note

Bio-FD&C Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bio-FD&C Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Income from Continuing Operations
â‚©5.6B
CAGR 3-Years
31%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Income from Continuing Operations
â‚©183.8B
CAGR 3-Years
-31%
CAGR 5-Years
-5%
CAGR 10-Years
6%
SK Bioscience Co Ltd
KRX:302440
Income from Continuing Operations
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Income from Continuing Operations
â‚©119.4B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Income from Continuing Operations
â‚©88.1B
CAGR 3-Years
22%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Income from Continuing Operations
-â‚©5.1B
CAGR 3-Years
41%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

Bio-FD&C Co Ltd
Glance View

Market Cap
117.9B KRW
Industry
Biotechnology

Bio-FD&C Co., Ltd. engages in the development of bio and health technologies. The company is headquartered in Incheon, Incheon and currently employs 61 full-time employees. The company went IPO on 2022-02-21. The firm is mainly engaged in the manufacture and sale of soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, acanthopanax koreanum adventitious root culture extract. The firm's products are mainly used as materials for cosmeceuticals, health functional foods and pharmaceuticals.

Intrinsic Value
15 556.25 KRW
Undervaluation 11%
Intrinsic Value
Price
B

See Also

What is Bio-FD&C Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
5.6B KRW

Based on the financial report for Dec 31, 2023, Bio-FD&C Co Ltd's Income from Continuing Operations amounts to 5.6B KRW.

What is Bio-FD&C Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
69%

Over the last year, the Income from Continuing Operations growth was 29%. The average annual Income from Continuing Operations growth rates for Bio-FD&C Co Ltd have been 31% over the past three years , 69% over the past five years .

Back to Top